drugset

drugset / Trial / NCT00171236

Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

NCT00171236 ↗

Phase 3 Completed 84 enrolled Novartis

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia

Timeline

Start: 2001-10
Primary completion: 2005-03
Completion: 2005-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fluvastatin	Other / unclassified	—	—

Indications